Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2695

Actual shortage: 246 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2440 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MOMETASONE 0.1% OINTMENT Actual shortage 2024-02-29 2024-06-07 220986
TEVA-SIMVASTATIN 5MG TABLET Actual shortage 2023-07-11 2024-06-07 198303
TEVA-SIMVASTATIN 5MG TABLET Actual shortage 2023-08-17 2024-06-07 202252
TEVA-SIMVASTATIN 20MG TABLET Actual shortage 2023-07-11 2024-06-07 198306
TEVA-OMEPRAZOLE 10MG TABLET (DELAYED-RELEASE) Actual shortage 2024-01-25 2024-06-07 217231
TEVA-CANDESARTAN 32MG TABLET Actual shortage 2024-03-28 2024-06-07 223853
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-06-07 209148
TEVA-ENTACAPONE 200MG TABLET Actual shortage 2024-05-30 2024-06-07 229227
TEVA-TOBRAMYCIN 60MG SOLUTION Actual shortage 2024-05-09 2024-06-07 227495
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-06-07 222572
TEVA-CINACALCET 90MG TABLET Actual shortage 2024-04-11 2024-06-07 224913
TEVA-CINACALCET 60MG TABLET Actual shortage 2024-04-11 2024-06-07 224910
TEVA-CINACALCET 30MG TABLET Actual shortage 2024-04-11 2024-06-07 224907
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-05-16 2024-06-07 228143
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Actual shortage 2024-03-07 2024-06-07 221537
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-06-07 221534
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-05-03 2024-06-07 226945
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-06-07 215751
TEVA-RIVAROXABAN 20MG TABLET Actual shortage 2024-05-09 2024-06-07 227456
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-06-07 223856

Showing 2661 to 2680 of 2695

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PRAMIPEXOLE 1.5MG TABLET Discontinued 2017-06-27 2017-06-27 14007
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
ZOLEDRONIC ACID INJECTION 5MG SOLUTION Discontinued 2017-06-27 2017-06-27 14030
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
TEVA-FUROSEMIDE 20MG TABLET Discontinued 2017-06-27 2017-06-27 14039
TEVA-FUROSEMIDE 40MG TABLET Discontinued 2017-06-27 2017-06-27 14042
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-CARBAMAZEPINE 200MG TABLET Discontinued 2017-06-27 2017-06-27 14052
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946

Showing 1 to 20 of 250